In the battle against HIV/AIDS conditions on the frontlines are constantly in flux as treatment, research and policy evolve.  The landmark HIV Prevention Trials Network (HPTN) 052…

Drug maker Gilead Sciences Inc says federal health regulators have delayed a decision on whether to approve its drug Truvada as the first pill that prevents HIV infection.

Human immunodeficiency virus (HIV) superinfection may be as common as initial HIV infection and is not limited to high risk-populations, according to a new study led…

HIV superinfection, when a person with HIV could acquire a second, new strain of HIV, may occur as often as initial HIV infection in…

Millions of the world’s poorest people could have easier access to life-saving drugs if India introduces an air ticket tax to help fund purchases of…

While immediate postexposure treatment for suspected HIV is critical, pre-exposure preventive treatment is a newer method that may be effective for people in high-risk groups, states…

Americans are a step closer to being able to quickly determine in the privacy of their own homes whether they’re infected with HIV, the virus that causes AIDS.

An…

An FDA Advisory Panel unanimously recommended the approval of a new in-Home HIV Test yesterday afternoon. Local advocates are happy another weapon will be available in the fight against HIV.

“This…

A federal advisory committee on Tuesday unanimously approved over-the-counter sale of a rapid HIV test, acknowledging the need for new tools against an epidemic that is driven largely by people who don’t know…

WASHINGTON, D.C., May 11, 2012 - Who’s Positive, a national HIV awareness organization, today announced the results of a year-long online survey measuring support for over-the counter (OTC) HIV…

An advisory panel to the Food and Drug Administration is expected to vote Thursday on whether a drug already used to treat H.I.V. infection should also be approved to…

UC Davis Health System researchers are a step closer to launching human clinical trials involving the use of an innovative stem cell therapy to fight the virus that…

In a groundbreaking study published last year, scientists reported that effective treatment with HIV medications not only restores health and prolongs life in many HIV-infected patients, but also curtails…

California will test an HIV-prevention pill in an attempt to slow the spread of the disease in the state, researchers announced Tuesday.

The pill, which is already used to treat…

A new understanding of the initial interactions of human immunodeficiency virus type 1 (HIV-1) and dendritic cells is described by Boston University School of Medicine (BUSM) researchers…

Tall, with dark-green pointy leaves, the neem tree of India is known as the “village pharmacy.” As a child growing up in metropolitan New Delhi, Sonia Arora recalls on…

The pill-a-day approach to HIV prevention can be cost-effective in men who have sex with men, but only in those at high risk for infection, researchers reported.

In a complex…

Giving an AIDS-fighting drug to men who are at high risk of HIV infection would cost billions, but it might be worth it terms of reducing infection rates, U.S.…

WASHINGTON: In a major breakthrough in the fight against AIDS, scientists claim to have for the first time shown that human stem cells can be genetically engineered…

Anal cancer is on the rise among HIV-positive women, according to a Montefiore Medical Center study entitled, “High Prevalence of High Grade Anal Intraepithelial Neoplasia in HIV-Infected…

A vaccine that may prevent HIV has been given the green light by the U.S. Food and Drug Administration to begin clinical trials in humans, according to Canadian researchers.

The announcement…

Temporary anti-retroviral therapy during the first stage of HIV infection can delay the time to long-term treatment, researchers reported.

In a randomized trial, early treatment reduced the so-called viral set point…

The FDA has expanded the indication for etravirine (Intelence) to include treatment of HIV-1 in pediatric patients ages 6 and older in combination with other anti-retroviral medication.

The expansion means…

A study in this week’s PLoS Medicine suggests that when people are first infected with HIV (primary HIV infection), temporary treatment with antiretroviral drugs (cART)…

Researchers from Boston University School of Medicine (BUSM) and Fenway Health have found that highly active antiretroviral therapy (HAART) does not completely suppress HIV in…